These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8226428)

  • 21. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G; Passot S; Lucht F; Dorche G
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
    Sieradzki K; Villari P; Tomasz A
    Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
    Tabe Y; Nakamura A; Igari J
    J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.
    Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC
    World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
    Garrett DO; Jochimsen E; Murfitt K; Hill B; McAllister S; Nelson P; Spera RV; Sall RK; Tenover FC; Johnston J; Zimmer B; Jarvis WR
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):167-70. PubMed ID: 10100541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact?
    Dunne WM; Qureshi H; Pervez H; Nafziger DA
    Clin Infect Dis; 2001 Jul; 33(1):135-7. PubMed ID: 11389509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis.
    Rådberg G; Nilsson LE; Kihlström E; Maller R; Sörén L
    J Antimicrob Chemother; 1992 Oct; 30(4):489-96. PubMed ID: 1490921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vancomycin, teicoplanin, and cefuroxime on Staphylococcus epidermidis adherence to intraocular lenses.
    Ozkan B; Karabaş VL; Gündeş S; Altintaş O; Etiler N; Cağlar Y
    J Cataract Refract Surg; 2005 Sep; 31(9):1814-20. PubMed ID: 16246789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.
    Cremniter J; Slassi A; Quincampoix JC; Sivadon-Tardy V; Bauer T; Porcher R; Lortat-Jacob A; Piriou P; Judet T; Herrmann JL; Gaillard JL; Rottman M
    J Clin Microbiol; 2010 Apr; 48(4):1428-31. PubMed ID: 20164270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anomalous growth of Staphylococcus epidermidis in the presence of Silastic and glycopeptide antibiotics.
    Hamilton-Miller JM; Shah S; Smith C
    FEMS Microbiol Lett; 1993 Oct; 113(2):145-7. PubMed ID: 8262364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics.
    Monzón M; Oteiza C; Leiva J; Lamata M; Amorena B
    Diagn Microbiol Infect Dis; 2002 Dec; 44(4):319-24. PubMed ID: 12543535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
    Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycopeptide resistance in Staphylococcus haemolyticus during treatment with teicoplanin.
    Blans M; Troelstra A
    Infect Control Hosp Epidemiol; 2001 May; 22(5):263-4. PubMed ID: 11428432
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
    Barr JG; Smyth ET; Hogg GM
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.